EUVIMEDEUVIMED entdecken
Open Access

Toward Clinical Generative AI: Conceptual Framework

Nicola Luigi Bragazzi iD, Sergio Garbarino iD

JMIR AI · 07.06.2024 · 3 · e55957

DOI: 10.2196/55957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JMIR AI, online erschienen am 07.06.2024. Verfasst von Nicola Luigi Bragazzi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Human Nutrition Unit, Department of Food and Drugs, University of Parma, Parma, Italy. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clinical decision-making is a crucial aspect of health care, involving the balanced integration of scientific evidence, clinical judgment, ethical considerations, and patient involvement. This process is dynamic and multifaceted, relying on clinicians’ knowledge, experience, and intuitive understanding to achieve optimal patient outcomes through informed, evidence-based choices. The advent of generative artificial intelligence (AI) presents a revolutionary opportunity in clinical decision-making. AI’s advanced data analysis and pattern recognition capabilities can significantly enhance the diagnosis and treatment of diseases, processing vast medical data to identify patterns, tailor treatments, predict disease progression, and aid in proactive patient management. However, the incorporation of AI into clinical decision-making raises concerns regarding the reliability and accuracy of AI-generated insights. To address these concerns, 11 “verification paradigms” are proposed in this paper, with each paradigm being a unique method to verify the evidence-based nature of AI in clinical decision-making. This paper also frames the concept of “clinically explainable, fair, and responsible, clinician-, expert-, and patient-in-the-loop AI.” This model focuses on ensuring AI’s comprehensibility, collaborative nature, and ethical grounding, advocating for AI to serve as an augmentative tool, with its decision-making processes being transparent and understandable to clinicians and patients. The integration of AI should enhance, not replace, the clinician’s judgment and should involve continuous learning and adaptation based on real-world outcomes and ethical and legal compliance. In conclusion, while generative AI holds immense promise in enhancing clinical decision-making, it is essential to ensure that it produces evidence-based, reliable, and impactful knowledge. Using the outlined paradigms and approaches can help the medical and patient communities harness AI’s potential while maintaining high patient care standards.

Schlagwörter

Stichwörter der Autor:innen

abductionartificial intelligencebenchmarkingclinical intelligenceiterative processverification paradigms

Autor:innen und Institutionen

  • Human Nutrition Unit, Department of Food and Drugs, University of Parma, Parma, Italy.
  • Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Maternal/Child Sciences, University of Genoa, Genoa, Italy.

ORCID-Profile: Nicola Luigi Bragazzi, Sergio Garbarino

Zitieren

APA

Bragazzi, N. L., & Garbarino, S. (2024). Toward Clinical Generative AI: Conceptual Framework. JMIR AI, 3, e55957. https://doi.org/10.2196/55957

Vancouver

Bragazzi NL, Garbarino S. Toward Clinical Generative AI: Conceptual Framework. JMIR AI. 2024;3:e55957. doi:10.2196/55957

BibTeX
@article{Bragazzi2024,
  author = {Bragazzi, Nicola Luigi and Garbarino, Sergio},
  title = {Toward Clinical Generative AI: Conceptual Framework},
  journal = {JMIR AI},
  year = {2024},
  volume = {3},
  pages = {e55957},
  doi = {10.2196/55957}
}
Kostenlos starten →